Splicing Mechanisms and Spliceosome Biology

  • RNA splicing is an essential process in eukaryotic gene expression in which introns are removed from precursor messenger RNA (pre-mRNA), and exons are joined to produce mature RNA molecules. It is a central stage of RNA processing and plays an important role in gene regulation, transcript diversity, protein production, and cellular function. The process is primarily carried out by a large molecular complex called the spliceosome, which recognizes specific RNA sequences and coordinates the precise removal of introns. Understanding splicing mechanisms and spliceosome biology is important in molecular biology, transcriptomics, genetics, and bioinformatics because alterations in RNA splicing can influence gene expression, protein structure, development, and disease.
  • Most protein-coding genes in eukaryotes contain exons and introns. Exons are sequences retained in mature RNA, while introns are intervening sequences that are generally removed during RNA processing. Following transcription, pre-mRNA contains both types of sequences and must undergo splicing before it can function as mature messenger RNA. Splicing requires accurate recognition of exon–intron boundaries, removal of introns, and joining of adjacent exons. Errors in this process can change the coding sequence, disrupt reading frames, introduce premature termination codons, or alter the stability and translation of RNA molecules.
  • The major signals involved in conventional pre-mRNA splicing include the 5′ splice site, the branch point sequence, the polypyrimidine tract, and the 3′ splice site. The 5′ splice site is generally located at the beginning of an intron and commonly contains a GU dinucleotide in the RNA sequence. The branch point is an important intronic sequence containing a conserved adenine nucleotide that participates directly in the splicing reaction. The polypyrimidine tract, rich in cytosine and uracil, is usually located upstream of the 3′ splice site. The 3′ splice site commonly ends with an AG dinucleotide. These sequence features are important recognition signals, although their exact sequences and strengths vary among genes and organisms.
  • The spliceosome is a dynamic ribonucleoprotein complex composed of small nuclear ribonucleoproteins (snRNPs), proteins, and associated RNA molecules. The five major spliceosomal snRNPs are U1, U2, U4, U5, and U6. Each snRNP contains a small nuclear RNA (snRNA) associated with several proteins. These components recognize splice sites, organize the pre-mRNA, catalyse the splicing reactions, and help release the processed RNA and intron. The spliceosome is not a permanently assembled structure; it forms through a series of ordered assembly, rearrangement, catalytic, and disassembly steps.
  • Spliceosome assembly begins when U1 snRNP recognizes and binds the 5′ splice site through base pairing between U1 snRNA and the pre-mRNA sequence. Proteins associated with the branch point and 3′ splice-site region help identify the other essential splicing signals. Splicing factor 1 (SF1) and U2 auxiliary factor (U2AF) participate in early recognition of the branch point and 3′ splice-site region. U2AF65 commonly binds the polypyrimidine tract, while U2AF35 helps recognize the 3′ splice-site region. These early interactions contribute to the formation of the initial spliceosomal recognition complex.
  • During the next stage, U2 snRNP is recruited to the branch point sequence. U2 snRNA base-pairs with the branch point region, leaving the branch point adenine available for the first catalytic reaction. This arrangement is important because the branch point adenine acts as the nucleophile that initiates intron removal. Recruitment of U2 snRNP produces a more stable pre-catalytic complex and prepares the RNA for the incorporation of additional spliceosomal components.
  • The U4/U6.U5 tri-snRNP is then recruited to the assembling spliceosome. This complex contains U4, U6, and U5 snRNPs. U4 initially interacts with U6 and helps maintain U6 in an inactive configuration before catalytic activation. U5 snRNP helps align the two exons that will be joined. Following recruitment, several RNA–RNA and RNA–protein rearrangements occur. U1 is displaced from the 5′ splice site, and U6 takes over important interactions with the 5′ splice-site region. U4 is released from U6, allowing U6 to participate in the catalytic centre of the spliceosome. U2 and U6 snRNAs form an important RNA-based catalytic structure that helps coordinate the splicing reactions.
  • The catalytic process of conventional pre-mRNA splicing involves two sequential transesterification reactions. During the first reaction, the 2′ hydroxyl group of the branch point adenine attacks the phosphate at the 5′ splice site. This reaction separates the 5′ exon from the intron and forms a lariat structure in which the 5′ end of the intron is linked to the branch point adenine through an unusual 2′–5′ phosphodiester bond. During the second reaction, the newly exposed 3′ hydroxyl group of the upstream exon attacks the phosphate at the 3′ splice site. This joins the two exons through a conventional 3′–5′ phosphodiester bond and releases the intron lariat.
  • The overall splicing reaction can be summarized as:
    • Pre-mRNA → Spliced mRNA + Intron lariat
  • The first catalytic reaction forms the intron lariat, while the second reaction joins the exons and releases the intron. The intron lariat is subsequently debranched and degraded in most cases, while the mature mRNA can undergo further processing, nuclear export, and translation. Spliceosomal components are also recycled for additional rounds of splicing.
  • Splicing is a highly regulated process rather than a simple removal of all introns according to fixed sequence boundaries. Alternative splicing occurs when different combinations of splice sites are selected from the same pre-mRNA. This allows a single gene to produce multiple transcript isoforms. The major alternative splicing patterns include exon skipping, alternative 5′ splice-site selection, alternative 3′ splice-site selection, intron retention, mutually exclusive exons, and alternative first or last exons. These events can modify protein-coding regions, untranslated regions, transcript stability, and gene regulation.
  • Splice-site selection is influenced by the strength of splice-site sequences and the activity of regulatory RNA-binding proteins. Strong splice sites are generally recognized more efficiently, while weak splice sites are more dependent on regulatory factors. Splicing enhancers and silencers are short RNA sequences that influence splice-site recognition. Exonic splicing enhancers (ESEs) and intronic splicing enhancers (ISEs) promote splice-site usage, whereas exonic splicing silencers (ESSs) and intronic splicing silencers (ISSs) can inhibit it. Their effects depend on the binding of specific regulatory proteins and the surrounding RNA context.
  • Serine/arginine-rich (SR) proteins are important positive regulators of splicing. They can bind to splicing enhancer sequences and help recruit or stabilize spliceosomal components at nearby splice sites. Heterogeneous nuclear ribonucleoproteins (hnRNPs) are another major group of RNA-binding proteins that can suppress or promote particular splicing events depending on the protein, binding location, and cellular context. Other regulatory factors include RNA-binding proteins involved in tissue-specific splicing, such as NOVA, RBFOX, PTBP, and MBNL proteins. Their expression and activity help establish characteristic splicing patterns in different tissues and developmental stages.
  • Splicing is also connected to transcription. In many genes, RNA splicing takes place while RNA polymerase II is still producing the pre-mRNA. The speed of transcription can influence the time available for recognition of alternative splice sites. The C-terminal domain of RNA polymerase II interacts with several RNA-processing factors and helps coordinate transcription, splicing, and other stages of RNA maturation. Chromatin structure and histone modifications may also influence splice-site selection by affecting transcriptional activity and the recruitment of regulatory proteins. This relationship between transcription and RNA processing is often described as transcription-coupled splicing.
  • Post-translational modifications of splicing factors provide another level of regulation. Phosphorylation of SR proteins and other spliceosomal components can influence their localization, interactions, and activity. Cellular signalling pathways may therefore alter splicing patterns in response to growth factors, stress, hormones, nutrient availability, and environmental conditions. These regulatory mechanisms allow cells to adjust transcript production according to their physiological requirements.
  • Not all introns are processed by the conventional major spliceosome. A smaller group of introns, known as minor-class introns, is processed by the minor spliceosome. The minor spliceosome contains specialized snRNPs called U11, U12, U4atac, and U6atac, together with U5, which is shared with the major spliceosome. It recognizes a distinct group of splice-site sequences and processes a relatively small number of introns in the human genome. Although minor introns are less common, they occur in genes involved in important cellular functions, and defects in their processing can have significant biological consequences.
  • Alternative splicing can influence the structure and function of proteins by changing their amino acid sequences. Exon inclusion may introduce or remove protein domains, catalytic regions, binding sites, signal peptides, or transmembrane segments. Some isoforms may have different subcellular localization or interaction partners. Other transcripts may contain premature termination codons and become targets of nonsense-mediated mRNA decay (NMD). This mechanism helps eliminate certain abnormal or regulated transcripts and connects RNA splicing with cellular RNA quality control. Alternative splicing can therefore regulate both protein diversity and the abundance of individual transcripts.
  • Splicing abnormalities can contribute to many inherited and acquired diseases. Mutations in canonical splice sites may disrupt normal intron removal, while changes in exonic or intronic regulatory sequences can alter the selection of alternative splice sites. Variants in genes encoding spliceosomal proteins or regulatory factors can also affect RNA processing across multiple genes. Abnormal splicing has been associated with cancers, neurological disorders, muscular diseases, blood disorders, and developmental conditions. In cancer, altered splicing can produce protein isoforms that influence cell proliferation, apoptosis, metabolism, tumour progression, and resistance to treatment.
  • Bioinformatics plays an important role in studying splicing mechanisms and spliceosome biology. RNA-seq data can be used to identify exon–exon junctions, alternative splicing events, and changes in transcript abundance. Splice-aware alignment tools such as STAR and HISAT2 map sequencing reads across exon–exon junctions and help identify potential splicing patterns. Transcript assembly and quantification tools such as StringTie, Salmon, and kallisto support transcript reconstruction and isoform abundance estimation. Long-read sequencing analysis can provide additional evidence for complete transcript structures and complex exon combinations.
  • Specialized tools are used to identify and quantify differential splicing. rMATS detects differential alternative splicing events between experimental conditions using replicated RNA-seq data. SUPPA2 estimates splicing events from transcript abundance measurements. MAJIQ identifies local splicing variations, while LeafCutter detects differential intron usage using split-read information. These tools can help identify changes in exon inclusion, splice-site selection, intron retention, and other RNA-processing events. Their results depend on sequencing quality, read coverage, annotation completeness, sample size, and statistical assumptions.
  • One important measurement in splicing analysis is percent spliced in (PSI), which estimates the proportion of transcripts containing a particular exon or splicing feature. For a simple exon-skipping event, it can be expressed as:
  • PSI = Inclusion-supporting reads / (Inclusion-supporting reads + Exclusion-supporting reads)
  • Here, inclusion-supporting reads provide evidence that the exon is included in the transcript, while exclusion-supporting reads provide evidence that it is skipped. PSI ranges from 0 to 1, or from 0% to 100% when expressed as a percentage. Actual computational methods may apply event-specific normalization and statistical models to account for read coverage and the structure of the splicing event.
  • Differential splicing analysis compares PSI values or other splicing measurements between experimental conditions. The difference in exon inclusion can be expressed as:
    • ΔPSI = PSI(condition 1) − PSI(condition 2)
  • A positive ΔPSI indicates greater exon inclusion in condition 1, while a negative value indicates reduced inclusion relative to condition 2. Statistical testing and multiple testing correction are used to determine whether the observed differences are likely to be reproducible rather than random variation.
  • Splicing analysis also requires reliable reference annotations and gene identifiers. Resources such as Ensembl, GENCODE, RefSeq, and UCSC Genome Browser provide gene models, exon structures, transcript annotations, and genomic coordinates. The choice of reference genome assembly and transcript annotation release can affect the identification and quantification of transcript isoforms. Researchers should therefore document the genome version, annotation release, alignment settings, and transcript definitions used in their analyses.
  • Experimental validation is essential for confirming important computational predictions. Reverse transcription PCR (RT-PCR) can identify different transcript products by amplifying regions surrounding alternative exons. Gel electrophoresis can distinguish products of different sizes, while RT-qPCR with isoform-specific primers can quantify selected transcript variants. Sanger sequencing of amplified products can confirm exon–exon junctions and transcript structures. Long-read sequencing can provide additional evidence about complete transcript isoforms. Functional studies may then investigate whether the identified splicing differences affect protein production, cellular activity, or biological traits.
  • In animal genomics and quantitative genetics, spliceosome biology is relevant to understanding variation in growth, development, reproduction, production efficiency, immunity, and environmental adaptation. Differences in splicing-factor activity or transcript isoform abundance may influence the function of genes involved in muscle development, milk synthesis, fertility, metabolism, and disease resistance. For example, alternative splicing of genes involved in muscle regulation may produce protein isoforms with different structural or functional properties. Splicing differences in immune-related genes may also contribute to variation in responses to infectious diseases. Studying these processes can help connect genetic variation with molecular mechanisms underlying economically important animal traits.
  • Splicing mechanisms and spliceosome biology therefore provide a fundamental understanding of how eukaryotic cells process RNA and regulate gene expression. The coordinated activity of spliceosomal snRNPs, RNA-binding proteins, splice-site sequences, and regulatory mechanisms ensures accurate intron removal while allowing alternative transcript production. Combining molecular biology, RNA sequencing, transcript isoform analysis, computational tools, and experimental validation enables researchers to investigate normal and abnormal splicing patterns. These approaches are valuable for understanding gene regulation, disease mechanisms, biological diversity, and complex traits in humans, animals, plants, and other eukaryotic organisms.
Author:

Leave a Reply

Your email address will not be published. Required fields are marked *